STOCK TITAN
  1. Home
  2. Sec-filings
  3. AGL
  4. [Form 4] agilon health, inc. Insider Trading Activity

Director Silvana Battaglia receives 2,133 RSUs at agilon health (AGL)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Battaglia Silvana reported acquisition or exercise transactions in this Form 4 filing.

agilon health, inc. director Silvana Battaglia received an equity award of 2,133 restricted stock units, granted at no cash cost and reported as Common Stock. These RSUs vest in full on June 2, 2027, if she continues serving as a director. Following this grant, her beneficial ownership is 7,926 shares, which includes restricted stock units and reflects a 1-for-25 reverse stock split that became effective on March 30, 2026.

Positive

  • None.

Negative

  • None.
Insider Battaglia Silvana
Role null
Type Security Shares Price Value
Grant/Award Common Stock 2,133 $0.00 --
Holdings After Transaction: Common Stock — 7,926 shares (Direct, null)
Footnotes (1)
  1. Restricted stock units that vest in full on June 2, 2027, subject to continued service as a director. The amount of securities beneficially owned following the reported transaction reflects the 1 for 25 reverse stock split of the Issuer's issued and outstanding common stock effective March 30, 2026. Includes restricted stock units.
RSU grant size 2,133 restricted stock units Equity award to director on June 2, 2026
Price per share $0.0000 per share Grant/award acquisition, no cash paid
Shares owned after grant 7,926 shares Total beneficial ownership following transaction, includes RSUs
RSU vesting date June 2, 2027 Units vest in full, subject to continued board service
Reverse stock split ratio 1-for-25 Effective March 30, 2026, applied to issued and outstanding stock
Transaction date June 2, 2026 Date of RSU grant reported on Form 4
restricted stock units financial
"Restricted stock units that vest in full on June 2, 2027, subject to continued service as a director."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
beneficially owned financial
"The amount of securities beneficially owned following the reported transaction reflects the 1 for 25 reverse stock split..."
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
reverse stock split financial
"reflects the 1 for 25 reverse stock split of the Issuer's issued and outstanding common stock effective March 30, 2026."
A reverse stock split is when a company reduces the number of its shares outstanding, making each share more valuable. For example, if you own 100 shares worth $1 each, a 1-for-10 reverse split would turn your 100 shares into 10 shares worth $10 each. Companies often do this to boost their stock price and appear more stable to investors.
Common Stock financial
"security_title: Common Stock"
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
Grant, award, or other acquisition financial
"transaction_code_description: Grant, award, or other acquisition"
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Battaglia Silvana
(Last)(First)(Middle)
C/O AGILON HEALTH, INC.
440 POLARIS PARKWAY, SUITE 550
(Street)
WESTERVILLE OHIO 43082
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
agilon health, inc. [ AGL ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/02/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock06/02/2026A2,133(1)A$07,926(2)(3)D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Restricted stock units that vest in full on June 2, 2027, subject to continued service as a director.
2. The amount of securities beneficially owned following the reported transaction reflects the 1 for 25 reverse stock split of the Issuer's issued and outstanding common stock effective March 30, 2026.
3. Includes restricted stock units.
Remarks:
/s/ Mimi Yang, as Attorney-in-Fact06/04/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What did Silvana Battaglia report in this agilon health (AGL) Form 4?

Silvana Battaglia reported receiving 2,133 restricted stock units of agilon health as an equity award. The grant involves no cash purchase and is part of her director compensation, increasing her total beneficial ownership to 7,926 shares after the transaction.

When do Silvana Battaglia’s new agilon health (AGL) RSUs vest?

The 2,133 restricted stock units vest in full on June 2, 2027, subject to her continued service as a director. If she remains on the board through that date, the units convert into shares of common stock, adding to her existing holdings.

Is Silvana Battaglia buying or selling agilon health (AGL) stock in this filing?

This Form 4 shows an acquisition through a grant, not an open-market buy or sale. Battaglia received 2,133 restricted stock units as compensation, increasing her total beneficial ownership to 7,926 shares, which includes previously granted restricted stock units.

How many agilon health (AGL) shares does Silvana Battaglia own after this grant?

After the grant, Battaglia beneficially owns 7,926 shares of agilon health common stock, including restricted stock units. This figure already reflects the company’s 1-for-25 reverse stock split that affected issued and outstanding shares effective March 30, 2026.

How does agilon health’s reverse stock split affect this Form 4 for AGL?

The filing states that Battaglia’s beneficial ownership after the grant reflects a 1-for-25 reverse stock split effective March 30, 2026. This means prior share and unit amounts were proportionally adjusted, so the 7,926 shares shown are on a post-split basis.